-
Published 10/14/2026
Vo H, Mehendale AM, Azzam M, Pilvar A, El Adili F, Patel R, Chamis B, Ramasubramanian A, Kissin B, York M, Trojanowski M, Jafarzadeh SR, Browning J, Bhawan J, Roblyer D, Bujor AM. Spatial frequency domain imaging for assessment of skin fibrosis in systemic sclerosis: a prospective cohort study. Lancet Rheumatol. 2026 Oct 14. PMID: 42874627.
-
Published 5/11/2026
Lui JK, Patel R, Luong HL, Au M, El-Adili F, Chamis B, Trojanowski MA, LaValley MP, Gopal DM, Klings ES, Bujor AM. Cytokine Profiling of Systemic Sclerosis-Related Pulmonary Hypertension. Arthritis Rheumatol. 2026 May 11. PMID: 42112843.
-
Published 2/4/2026
Lui JK, Cozzolino M, Winburn M, Trojanowski MA, LaValley MP, Bujor AM, Gopal DM, Klings ES. Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain. Rheumatology (Oxford). 2026 Feb 04; 65(2). PMID: 41615697.
-
Published 2/4/2026
Kaundal U, Tsou PS, Sahu M, Huang M, Boyden SE, Woodford CM, Shriner D, Stenson E, Safran SA, Zhou Y, Talley TA, Gudapati K, Zhang X, Kunishita Y, Wang J, Shah AA, Mayes MD, Doumatey AP, Bentley AR, Domsic R, Medsger TA, Ramos PS, Silver RM, Steen V, Varga J, Hsu V, Saketkoo LA, Schiopu E, Gordon JK, Criswell LA, Gladue H, Derk C, Bernstein EJ, Bridges SL, Shanmugam V, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Mullikin J, Thomas JW, Dell'Orso S, Randazzo D, Adeyemo A, Remmers EF, Schwartzberg PL, Aksentijevich I, Rotimi C, Wigley FM, Wang RA, Boin F, Khanna D, Lafyatis R, Kastner DL, Gourh P. Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis. Ann Rheum Dis. 2026 Jul; 85(7):1396-1412. PMID: 41644364.
-
Published 12/1/2025
Khanna D, Spino C, Tashkin DP, Bernstein EJ, Goldin J, Kleerup EC, Harui A, Ibrahim G, Kim GHJ, Huang S, McLain R, Tu YH, Nagaraja V, Silver RM, Steen VD, Weigt SS, Lee JS, Fischer A, Scholand MB, Gordon JK, Dellaripa PF, Rosas IO, Hunninghake GM, Trojanowski MA, Simms RW, Dematte JE, Hsu VM, Domsic RT, Raghu G, Mayes MD, Boente RD, Roth MD. Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. ACR Open Rheumatol. 2025 Dec; 7(12):e70126. PMID: 41294296.